Mitomycin and Skin disorder - a phase IV clinical study of FDA data

Summary:

Skin disorder is reported as a side effect among people who take Mitomycin (mitomycin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Doxorubicin Hydrochloride, and have Hepatic neoplasm malignant recurrent.

The phase IV clinical study analyzes which people have Skin disorder when taking Mitomycin. It is created by eHealthMe based on reports of 4,183 people who have side effects when taking Mitomycin from the FDA, and is updated regularly.

What is Mitomycin?

Mitomycin has active ingredients of mitomycin. eHealthMe is studying from 4,195 Mitomycin users. Check the latest studies of Mitomycin.

What is Skin disorder?

Skin disorder (skin disease) is found to be associated with 1,546 drugs and 1,450 conditions by eHealthMe. Check the latest studies of Skin disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,183 people reported to have side effects when taking Mitomycin.
Among them, 12 people (0.29%) have Skin disorder.

Among these 12 people:

How long have people been on Mitomycin when they have Skin disorder? *

What is the gender of people who have Skin disorder when taking Mitomycin? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Skin disorder when taking Mitomycin? *

What are other drugs people take besides Mitomycin? *

Doxorubicin Hydrochloride: 4 people, 33.33%
Vinorelbine: 2 people, 16.67%
Lipiodol: 2 people, 16.67%
Trabectedin: 1 person, 8.33%
Topotecan: 1 person, 8.33%
Sorafenib: 1 person, 8.33%
Pantoprazole: 1 person, 8.33%
Gemzar: 1 person, 8.33%
Fluphenazine: 1 person, 8.33%
Fluorouracil: 1 person, 8.33%

What are other side effects people have besides Skin disorder? *

Hepatobiliary Disease (diseases affect the liver and/or biliary tract): 2 people, 16.67%
Cardiac Disorder: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Eye Disorder: 2 people, 16.67%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 16.67%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 2 people, 16.67%
Death: 2 people, 16.67%
Fever: 2 people, 16.67%
Lymphatic Disorder (disease of lymphatic system): 2 people, 16.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 16.67%

What are the existing conditions these people have? *

Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent): 4 people, 33.33%
Tumor: 1 person, 8.33%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 8.33%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 8.33%
Bladder Cancer: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mitomycin and have Skin disorder?

- Check whether Skin disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mitomycin:

Mitomycin (4,195 reports)

Skin disorder treatments and more:

Skin disorder (41,532 reports)

Browse all side effects of Mitomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin disorder:

Skin disorder (1,546 drugs)

Browse all the conditions that are associated with Skin disorder:

Skin disorder (1,450 conditions)

Related publications that referenced our studies

Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on mitomycin (the active ingredients of Mitomycin) and Mitomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.